Fidia Farmaceutici buys controlling stake in Meditrina Pharmaceuticals

Business Forum
Italian pharmaceutical company Fidia Farmaceutici, specializing in regenerative medicine and the use of hyaluronic acid in advanced therapeutic applications, has purchased a majority stake in Meditrina Pharmaceuticals.

Meditrina Pharmaceuticals is a Romanian pharmaceutical distributor active in therapeutic areas such as dermatology, gynecology, urology, and nephrology. 

“This is a strategic transaction and reflects investors' confidence in the potential of the local pharmaceutical sector,” says Liliana Busoiu, Partner at EY Parthenon Financial Diligence Leader, Romania.

EY Romania has provided financial and tax advisory services to Fidia Farmaceutici.

RECOMMENDED
Romania sees more M&A deals on nine months
Industry

Romania sees more M&A deals on nine months

The Romanian mergers and acquisitions (M&A) market recorded 216 transactions in the first nine months (9M) of 2025, an 8.5% increase compared to the same period in 2024.

RECOMMENDED FROM THE HOME PAGE
Economy

Romania's inflation hits 10.85% in May 2026

Romania's annual inflation rate climbed to 10.85% in May from 10.71% in April, driven by rising costs across all sectors, according to data released by the National Institute of Statistics (INS).